3 years, 4 months ago

Patients unable to produce Covid antibodies supported by new drug

NL Times

The Erasmus Medical Center has begun using the drug REGEN-Cov to treat patients with Covid-19 who have a reduced ability to produce antibodies themselves. “You are buying time for patients to make their own antibodies”, said Bart Rijnders, an internist and infectious diseases specialist at the hospital. “In patients who will never produce their own antibodies, it helps the other immune systems in the body in their fight against the virus.” The hospital referred to the drug as a breakthrough. A British study showed that Covid-19 patients who did not yet have antibodies upon admission were able to be released four days earlier on average if they were treated with monoclonal antibodies.

Patients Covid Produce Antibodies Monoclonal Antibodies New Drug Rijnders unable monoclonal hospital antibodies treated covid rijnders sarscov2 supported produce drug virus patients covid19

History of this topic

1 year, 8 months ago

The COVID virus has mutated so much since 2019 that some experts say it should be renamed SARS-CoV-3

Salon

On Monday, April 10, President Joe Biden signed a bill that immediately terminated the COVID-19 national emergency, first enacted in 2020 as the SARS-CoV-2 virus gripped the country. "This virus remains unstable — it has not settled into a predictable pattern, which means surveillance systems need to be sensitive to pick up the early signs of another surge." Related Pandemic …

1 year, 10 months ago

'Coldspots' discovered in Covid virus, may help antibodies fight future variants: Study

India TV News

Scientists have discovered regions on the coronavirus which do not change, or 'coldspots', and that antibodies specific for these coldspots may help fight future coronaviruses, according to a new study. According to the study, sieving through over 10 million coronavirus sequences, two PhD students at the Institute for Research in Biomedicine, Switzerland and affiliated with the Università della Svizzera italiana, …

1 year, 10 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

1 year, 11 months ago

Dutch Covid hospital total falls 19% in a week; Sharp drop in known infections

NL Times

Hospitals in the Netherlands were treating 664 patients with Covid-19 on Tuesday, 19 percent fewer than a week earlier. Additionally, new infections diagnosed ing the past seven days by healthcare services, and not from self-test kits, fell below 4,500 to the lowest point since June 2021. The hospitalizations fell by nearly 27 percent since last Tuesday, when the average was …

2 years ago

Covid-19 vaccine protects patients with blood cancer: Study

Hindustan Times

People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from Covid-19. Covid-19 vaccine protects patients with blood cancer: Study A team led by physicians Dr. Andrea Keppler-Hafkemeyer and Dr. Christine Greil from the Medical Center-University of Freiburgand virologist Prof. Oliver T. Keppler from LMU Munich has now characterized in …

2 years, 7 months ago

New oral Covid vaccine can decrease severity, transmission: Study

India Today

An investigational Covid vaccine designed to be administered orally has not only limited the degree of the disease but also decreased its airborne spread during its trial on animals, revealed a study published in the journal, Science Translational Medicine, earlier this week. The research team led by Duke University researcher Stephanie N Langel, a medical instructor in the Department of …

2 years, 8 months ago

ICMR Study Has Shown Rise in Antibodies Post Covaxin Booster Dose: MoS Health Tells Rajya Sabha

News 18

An ICMR study to examine the effect of Covaxin's booster dose has shown an increase in the levels of antibodies against SARS-CoV-2, Minister of State for Health Bharati Pravin Pawar told the Rajya Sabha on Tuesday. International data available on booster doses of AstraZeneca and Covishield suggests a three- to four-fold increase in antibody levels after their administration, Pawar said …

2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

2 years, 9 months ago

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'

News 18

The EU’s drug watchdog on Thursday recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. The European Medicines Agency’s human medicines committee “has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years …

2 years, 9 months ago

Better to err on the side of caution to ensure public health during pandemic, TN tells SC

The Hindu

States like Tamil Nadu and Maharashtra in the Supreme Court on Tuesday justified their hardened stand to make COVID-19 inoculation mandatory, even at the cost of denying people their rights, by saying that it was better to err on the side of caution to prevent serious or irreversible harm to the public when there was insufficient information about the virus. …

2 years, 10 months ago

Anti-Covid drugs potent against Omicron, antibody therapies less effective: Study

Deccan Chronicle

Washington: The current drugs to treat COVID-19 remain very effective against the Omicron variant of the SARS-CoV-2 virus, according to a laboratory study. However, available antibody therapies -- typically given intravenously in hospitals -- are substantially less effective against Omicron compared to earlier variants of the virus, the researchers said. The clinically available pills and antibodies were designed and tested …

2 years, 11 months ago

Baricitinib, Sotrovimab: Two New Covid-19 Treatments Approved By WHO

News 18

The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus. In their recommendation in British medical journal the BMJ, WHO experts said arthritis drug baricitinib used with corticosteroids to treat severe or critical Covid patients led to better survival rates and …

3 years ago

Omicron can evade protection offered by COVID-19 vaccines, antibody therapies, says study

Firstpost

The study, published in the journal Nature on Thursday, also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus may soon evolve. Washington: Omicron can evade the immune protection conferred by COVID-19 vaccines and natural infection, according to a peer-reviewed study which also suggests that the new variant of coronavirus is completely resistant to antibody …

3 years ago

New antibody drug to boost COVID fight

China Daily

Editor's Note: The eyes of the world are turning to China. Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease. In an exclusive interview with China Daily, Zhang Linqi, leader of the research team and director of the …

3 years ago

New antibody drug to boost COVID fight

China Daily

3 years ago

New antibody drug to boost COVID fight

China Daily

chinadaily.com.cn| Updated :2021-12-24 Editor's Note: The eyes of the world are turning to China. Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease. In an exclusive interview with China Daily, Zhang Linqi, leader of the research team and …

3 years ago

Coronavirus antibodies in donated blood halves in two months

Dutch News

The amount of antibodies against coronavirus found in blood given by vaccinated blood donors has halved in two months, according to donation agency Sanquin. The longer ago people were vaccinated, the fewer antibodies they have, Sanquin said, following research on blood donated by 2,200 people. ‘Antibodies for respiratory infections usually decrease quickly over time,’ said microbiologist and researcher Hans Zaaijer. …

3 years ago

Coronavirus antibodies in donated blood halves in two months

Dutch News

3 years ago

New COVID-19 antibody drug OK’d to protect most vulnerable

LA Times

This image provided by AstraZeneca shows packaging and vials for the company’s Evusheld medication. Federal health officials on Wednesday authorized a COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions …

3 years, 1 month ago

Merck asks EU drug regulator to authorise its Covid-19 pill

Hindustan Times

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat Covid-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared. Last …

3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

3 years, 1 month ago

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir

India Today

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain's Medicines and Healthcare products Regulatory Agency recommended the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at …

3 years, 2 months ago

Covid-19 vaccines may protect against other coronaviruses: Study

India Today

Covid-19 vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, according to a study. The study found that plasma from humans who had been vaccinated against SARS-CoV-2 produced antibodies that were cross-reactive, or provided protection, against SARS-CoV-1 and the common cold coronavirus. Mice that had been immunised with Covid-19 vaccines and later were exposed to the …

3 years, 2 months ago

CureVac stops Covid-19 vaccine development; Netherlands was to receive 10.7 million doses

NL Times

German company CureVac announced on Tuesday that it stopped the development of its vaccine against Covid-19, the respiratory disease caused by the novel coronavirus. The Netherlands ordered some 10.7 million doses of this vaccine as part of its vaccination strategy. CureVac now withdrew its vaccine, CVnCoV, from regulatory review and terminated its agreement with the European Commission to buy 405 …

3 years, 2 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

3 years, 2 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu

3 years, 2 months ago

AstraZeneca asks FDA to authorize COVID antibody treatment

LA Times

AstraZeneca has asked the Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19. AstraZeneca, the drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease. The Anglo-Swedish company said Tuesday that the …

3 years, 2 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

3 years, 3 months ago

WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation

Firstpost

The Regeneron cocktail of synthetic antibodies - casirivimab and imdevimab - has been found to reduce the risk of hospitalisation for unvaccinated, elderly or immunosuppressed patients with Covid. The World Health Organization on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. Regeneron is only the third treatment for Covid to be …

3 years, 3 months ago

Cancer patients have protective immune response to Covid-19 vaccines without side-effects: Studies

India Today

People with cancer have an appropriate, protective immune response to Covid-19 vaccines without experiencing any more side-effects than the general population, researchers said on Tuesday. The participants comprised individuals without cancer, patients with cancer treated with immunotherapy, patients treated with chemotherapy and those treated with a chemo-immunotherapy combination. Data from another study was presented at the conference that was conducted …

3 years, 3 months ago

UK to roll out life-saving COVID-19 treatment which was given to Donald Trump

India TV News

Thousands of vulnerable health service patients in the UK hospitals due to COVID-19 are set to benefit from a life-saving new antibody treatment called Ronapreve, which was given to former US president Donald Trump. “We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled it will be saving lives …

3 years, 3 months ago

Covid-19 booster shots not urgently needed, EMA says

NL Times

It is not urgent to give fully vaccinated people a booster against the coronavirus in general, said the European Medicines Agency. The EMA also stressed the importance of “physical distancing, hand and respiratory hygiene, and using face masks.” This was especially true, it said, for places at high-risk of infection or where people are at a higher risk of developing …

3 years, 3 months ago

Antibody Tests Should Not Be Your Go-To For Checking COVID Immunity

NPR

Antibody Tests Should Not Be Your Go-To For Checking COVID Immunity Enlarge this image toggle caption Naveen Sharma/SOPA Images/LightRocket via Getty Naveen Sharma/SOPA Images/LightRocket via Getty Booster shots against the coronavirus have already started rolling out in the U.S. for some people and millions more could be due for them soon. Sponsor Message Unlike other COVID-19 tests that are used …

3 years, 4 months ago

Anti-vaccine, anti-mask governors push an experimental antibody therapy

LA Times

With COVID-19 hospitalizations soaring in Florida, Gov. Antibody cocktails, which must be given within 10 days of coronavirus infection or exposure, are effective for many patients, but “this is not a substitute for vaccine, by any means,” said Dr. Christian Ramers, chief of population health and an infectious-disease specialist at Family Health Centers of San Diego. The Food and Drug …

3 years, 4 months ago

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’

CNN

CNN — When Texas Gov. Monoclonal antibodies such as those made by Regeneron and GlaxoSmithKline won’t work for every Covid-19 patient; mAbs, as they are known, are only available for people age 12 and older and who aren’t hospitalized or severely ill. Regeneron’s therapy can also be used for some people who know they were exposed to the virus,but don’t …

3 years, 4 months ago

As Covid-19 cases spike US orders for monoclonal antibodies up 1200%

CNN

CNN — As coronavirus case numbers spike, the US has seen a 1,200% increase in orders for monoclonal antibody treatments in the past month, the US Health and Human Services Department told CNN Thursday. “This, applied early and properly, has the ability to reduce your likelihood of being hospitalized.” Studies show monoclonals are highly effective at preventing high-risk patients from …

3 years, 4 months ago

FDA set to clear third COVID-19 shot for people with weak immune systems

LA Times

U.S. drug regulators are set to clear a third dose of COVID-19 vaccines for people with weak immune systems as a new study showed the benefits of an extra shot in transplant patients. A third dose of Moderna Inc.’s vaccine significantly raised antibody levels against the coronavirus in transplant patients, according a comparison of an extra shot to a placebo …

3 years, 4 months ago

SARS-CoV-2 antibodies remain stable, even increase 7 months after infection: Study

Deccan Chronicle

Barcelona: According to a recent study in a cohort of healthcare workers, the levels of IgG antibodies against SARS-CoV-2 Spike protein remained stable, or even increased, seven months after the infection. The results, published in the journal 'Nature Communications', also supported the idea that pre-existing antibodies against common cold coronaviruses could protect against COVID-19. With this goal in mind, the …

3 years, 4 months ago

New Dutch Covid hospitalizations at five-day low; Infections at 24-day low

NL Times

Hospitals in the Netherlands recorded the lowest number of new hospitalizations for the treatment of Covid-19 in a week. While the admitted patient total continued its weeks-long rise, the increase slowed down significantly on Friday, with new coronavirus infections also falling to a 24-day low. While that was enough to raise the daily average up to 100 for the first …

3 years, 4 months ago

Covid-19 cocktail antibody injection therapy turned a boon against comorbidities

Deccan Chronicle

VIJAYAWADA: The Covid-19 cocktail antibody injections treatment is said to be yielding good results among high-risk people. Dr Lokesh Gutta, consultant interventional pulmonologist, Manipal Hospitals, Vijayawada, said that the combination of two recombinant human IgG1 monoclonal antibodies is mainly advantageous to patients with mild symptoms and who have existing comorbidities. Manipal Hospitals, Vijayawada, is the only one in the Telugu …

3 years, 5 months ago

Two-thirds of Indians have antibodies, shows ICMR survey - The Hindu

The Hindu

While two-thirds of the general population had SARS-CoV-2 antibodies, a third does not have antibodies, making approximately 40 crore people still vulnerable to infections, Indian Council of Medical Research Director General Balram Bhargava said on Tuesday. Presenting the results of the fourth national COVID serosurvey, Dr. Bhargava said States, districts and areas without antibodies run the risk of infection waves. …

3 years, 5 months ago

Two-thirds of Indians Have Covid Antibodies, Another 40 Crore Still Vulnerable to Infection: Govt

News 18

Around 40 crore people are still vulnerable to COVID-19 infection as a nationwide survey found two-thirds of the country’s population aged above six to have SARS-CoV-2 antibodies, the government said on Tuesday as it stressed there is no room for complacency in the fight against the pandemic. Addressing a press conference, a senior official said two-thirds or 67.6 per cent …

3 years, 5 months ago

40 cr Indians still vulnerable to Covid-19; 67% have antibodies, finds 4th Serosurvey

Live Mint

While releasing findings of the fourth national serosurvey, the Union Health Ministry today said that nearly two-thirds of the population in the country aged above six has developed antibodies against coronavirus, while 40 crore people are still vulnerable to the disease. "67.6% of India's population above 6 years found to have SARS-CoV-2 antibodies in ICMR's latest national serosurvey in June-July," …

3 years, 5 months ago

Covid-19 Antibodies Last at Least Nine Months After Infection, Study Finds

News 18

Antibody levels remain high nine months after infection with SARS-CoV-2, the virus that causes Covid-19, whether symptomatic or asymptomatic, according to a study published on Monday that analysed data from an entire Italian town. The study, published in the journal Nature Communications, found that 98.8 per cent of people infected in February and March showed detectable levels of antibodies in …

3 years, 5 months ago

Monoclonal antibody cocktail: Glimmer of hope against Covid-19

Hindustan Times

As the city’s management and medical experts prepare for an anticipated third wave of Covid-19, an experimental drug has offered a glimmer of hope against the virus. HT Image Known as monoclonal antibody cocktail, the drug’s response has been analysed in 199 patients who were admitted to Mumbai’s Seven Hills Hospital, and the findings are promising, say doctors. A 2020 …

3 years, 5 months ago

Antibody cocktail treatment can help Covid patients recover faster, reduces mortality: BMC

India Today

The Brihanmumbai Municipal Corporation on Monday said that antibody cocktail treatment can help Covid-19 patients recover faster and reduces mortality rate. The civic body's claim is based on an experiment of antibody cocktail conducted by Mumbai's Seven Hills hospital on 200 patients. ANTIBODY COCKTAIL FOR COVID-19 TREATMENT In order to successfully treat the affected patients and to alleviate the strain …

3 years, 5 months ago

Vaccines are terrific, but where are the COVID-19 treatments?

LA Times

Since the early days of the pandemic, we’ve all wanted to know when and how it will end. That research has yielded three authorized vaccines — so far — that are highly effective not just against the original virus but also against its many variants, including the highly transmissible Delta variant. Mehta spoke to The Times about which medicines are …

$Pfizer Covid vaccine induces \'good\' immune response against coronavirus variants$

3 years, 5 months ago

Pfizer Covid vaccine induces \'good\' immune response against coronavirus variants

Deccan Chronicle

London: Two doses of the Pfizer COVID-19 vaccine induce a "very good" antibody response against the SARS-CoV-2 variants, according to a study on 180 health care workers in Finland. The immune response was somewhat decreased against the Beta variant first found in South Africa, but the vaccine generated neutralising antibodies that give relatively good protection against the variant. They analysed …

3 years, 5 months ago

Oxford study says mixing COVID-19 vaccines gives good protection

Deccan Chronicle

London: Amid the global shortage of the COVID-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. "The Com-COV study has evaluated 'mix and match' combinations of the Oxford and Pfizer vaccines to see to what extent these vaccines can be used interchangeably, …

Discover Related

2 days, 9 hours ago

Patients are frustrated that there isn't a reliable treatment yet for long COVID

NPR

Patients are frustrated that there isn't a reliable treatment yet for long COVID Much of the NIH-funded research on long COVID has focused on observing and understanding the disease. SARAH BODEN, BYLINE: Erica Hayes lives north of Pittsburgh, and she's one of an estimated 17 million American adults with long COVID. And that's why some patients argue that the NIH …

Treatment Drugs Patients Long Covid Covid Long Stone

2 weeks, 5 days ago

Coronavirus FAQ: I didn't get the latest COVID vaccine. Should I? And if so ... when?

NPR

Coronavirus FAQ: I didn't get the latest COVID vaccine. Plus, "potentially preventing any COVID infection keeps you from being sick, getting long COVID and making someone sick who could really be at risk," says Jeffrey Townsend, a professor of evolutionary biology and head of a lab at the Yale School of Public Health that has been studying COVID throughout the …

Health Public Health Vaccines Countries Covid Infection Cdc

1 month, 1 week ago

Is it the flu or is it COVID? One at-home test can tell you

NPR

Is it the flu or is it COVID? One at-home test can tell you toggle caption iHealth Labs, Inc With the flu season getting underway, and COVID-19 still circulating, if you get sick you might wonder: 'Which virus got me this time?' For the first time, new home tests — available at pharmacies without a prescription — can test for …

Test Tests Help Covid Flu Fda Lias

1 month, 1 week ago

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin

Live Mint

MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part of this initiative, the National Institute of Allergy and Infectious Diseases, part of the …

Hyderabad Infectious Diseases Candidate Vaccine Mrna Niaid Project Nextgen

1 month, 3 weeks ago

India to undertake mega study of covid-19 samples to help prepare for future pandemics

Live Mint

New Delhi: The Department of Biotechnology plans to undertake a study of thousands of samples and clinical material collected during covid-19 to help Indian scientists understand the susceptibility of individuals and changes in metabolic activity that will be useful in fighting future pandemics. The department will give the Indian SARS-CoV-2 Genomics Consortium, a consortium of 54 laboratories, the mandate to …

India Indian Official Covid Studies Dbt Future Pandemics

1 month, 3 weeks ago

An 'unprecedented' good news story about a deadly viral outbreak

NPR

An 'unprecedented' good news story about a deadly viral outbreak toggle caption Ben Curtis/AP Marburg virus is notorious for its killing ability. “We believe this is the first time patients with Marburg virus have been extubated in Africa,” says Tedros Adhanom Ghebreyesus, director general of the World Health Organization. Sponsor Message “The health infrastructure, the health-care providers in Rwanda — …

Health Patients Care Outbreak Country Vaccines Rwanda

2 months, 2 weeks ago

10,000 Long Covid patients on benefits, more may follow

Dutch News

Some four years after the beginning of the Covid pandemic some 10,000 Long Covid sufferers are living on benefits because they are unable to work or work fulltime, figures from state benefits agency UWV have shown. Some 9,746 people are on invalidity benefit because of complications following an infection while another 1,246 have health problems associated with Long Covid but …

Long Covid Olde Loohuis Covid Long Infection

2 months, 2 weeks ago

10,000 Long Covid patients on benefits, more may follow

Dutch News

Long Covid Olde Loohuis Covid Long Infection

3 months, 1 week ago

What to know about the available Covid-19, flu and RSV vaccines

CNN

CNN — It’s that time of year when any cough or sniffle could be Covid-19, flu or RSV — but there are ways to fend them off. Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the …

Vaccines Cnn Covid Older Cdc Last Year Flu

3 months, 2 weeks ago

For people without insurance, updated Covid-19 shots are no longer free of charge at pharmacies

CNN

CNN — The rollout of updated Covid-19 vaccines has begun in the United States, but for the first time, the shots will no longer be free of charge for people without insurance at their local pharmacy. Last year, as the shots transitioned to the commercial market, the US Centers for Disease Control and Prevention’s Bridge Access Program provided free Covid-19 …

Health Insurance Local Vaccines Cost State Cnn

3 months, 3 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

Vaccines Covid Months Vaccine Bennett Booster Tga

3 months, 3 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

Public Health Vaccine Iil This Intranasal Vaccine Indian Immunologicals Ltd

3 months, 3 weeks ago

The new COVID vaccine is out — but you might not want to rush to get it

Raw Story

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with the latest covid outbreak sweeping the country, or hold it in reserve for the winter wave? “Covid is still very transmissible, very new, and people congregate inside in air-conditioned rooms during the summer,” …

Health Summer Vaccines New York Cdc Fda Vaccine

3 months, 3 weeks ago

Covid-19 infections pose a greater risk to heart than vaccines: Study

India Today

As concerns have risen about Covid-19 vaccines in increasing the risk myocarditis, a study have revealed that Covid-19 infections is more harmful for the heart than the vaccines. A recent study published in JAMA sheds light on this issue, revealing that the likelihood of developing myocarditis, a condition where the heart muscle becomes inflamed, often due to an immune response, …

Mrna Myocarditis Infections Pose

3 months, 4 weeks ago

New coronavirus vaccination round starts in the Netherlands

Dutch News

The government has launched a new coronavirus vaccination round for the over-60s and younger people with certain health conditions, and the first invitations for a jab arrived on Tuesday. Everyone over the age of 60 is being invited to have the vaccination by letter, while others considered to be at extra risk will be able to make an appointment via …

Ill

3 months, 4 weeks ago

New coronavirus vaccination round starts in the Netherlands

Dutch News

Ill

4 months ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

Virus Fda Vaccine Moderna Updated Shots Pfizer

4 months ago

The new COVID shot is now available. Here's what you need to know

NPR

The new COVID shot is now available. "But if we can prevent people from getting serious cases that end up in emergency rooms, hospitals or worse — dead — that’s what we’re trying to do with these vaccines.” Sponsor Message On average across all age groups, the two mRNA vaccines should cut the risk of having COVID-19 by 60% to …

Health Vaccines Marks Covid Shot Months Fda

4 months ago

COVID-19 variant KP.3.1.1 predominant in US as infections continue ticking up

China Daily

LOS ANGELES - The KP.3.1.1 COVID-19 variant, now the predominant SARS-CoV-2 variant circulating in the United States, has been causing increasing infections in the country, the latest data from the US Centers for Disease Control and Prevention showed. For the two-week period ending Aug 17, KP.3.1.1 is predicted to account for between 31 percent and 43 percent of COVID-19 clinical …

Cdc Period Ending

4 months ago

Covid tied to higher risk of depression, anxiety, PTSD and other conditions, with the unvaccinated most affected, study shows

CNN

Editor’s Note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained counselor, or visit the 988 Lifeline website. CNN — Having a severe case of Covid-19 appears to be linked with an increased risk of subsequent mental illness, …

Health Depression Mental Illness Risk Mental Cnn Covid

4 months, 2 weeks ago

Covid making worrying comeback amid summer surge and Olympics infections, WHO official warns

The Independent

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. A top official said the number of people testing positive for Covid across 84 countries …

Olympic Covid Cent Health Check

4 months, 2 weeks ago

Long Covid: New insights into symptoms, mechanisms and treatment prospects

Hindustan Times

Researchers from the Universities of Arizona, Oxford and Leeds examined dozens of previous studies on long Covid to investigate the number and range of people affected, the underlying disease mechanisms, the numerous symptoms that patients develop, and current and future treatments. Long Covid: New insights into symptoms, mechanisms and treatment prospects Long Covid, also known as post-Covid-19 condition, is described …

Treatment Long Covid Symptoms Covid Long Develop

4 months, 2 weeks ago

Olympics Sees 40-Plus COVID Cases as Global Infections Rise: WHO

Deccan Chronicle

Geneva: More than 40 athletes at the Paris Olympics have tested positive for Covid-19, highlighting a new global rise in cases as vaccination coverage plunges, the World Health Organization said Tuesday. Data from 84 countries shows that the percentage of positive tests for SARS-CoV-2 -- the virus that causes Covid-19 disease -- "has been rising for several weeks", she told …

Olympics Virus Paris Van Circulation Global Infections Severe Covid

4 months, 3 weeks ago

Scientists find arthritis drug may treat long Covid inflammation

India Today

Scientists have discovered a new cause of long Covid in the lungs. Their study, published in Science Translational Medicine, indicates that a treatment previously used for rheumatoid arthritis might be effective in halting the chronic inflammation associated with long Covid. The researchers at the University of Virginia School of Medicine analysed single-cell RNA sequencing data from the lower airways of …

Long Covid Covid Long Drug

5 months, 1 week ago

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive

Live Mint

New Delhi: With US President Joe Biden testing positive for COVID-19 before the Presidential elections, the World Health Organisation has warned the public that Covid is still not over. WHO director-general Tedros Adhanom Ghebreyesus issued a warning, stating that vaccination rates among health professionals and the over-60s—two demographics most at risk of dying from COVID—are alarmingly falling. Globally, 9.8 million …

Covid Tedros

5 months, 1 week ago

Covid cases are rising again, but chances of long-term complications are lower

Live Mint

A summer Covid wave is hitting the country, but there’s one consolation: Your chances of developing long Covid have fallen since the start of the pandemic. By contrast, the risk of developing long Covid dropped to 3.5% with the virus’s Omicron variant among vaccinated people. “There’s less virus to go around, to cause havoc, to persist in the tissues—all of …

Health Risk Long Covid Covid Long Virus Covid Cases

5 months, 2 weeks ago

‘Playing COVID roulette’: Some infected by FLiRT variants report their most unpleasant symptoms yet

LA Times

A large number of travelers make their way through Tom Bradley International Terminal at LAX during the busy July 4 holiday. Each time you get COVID, he said, is “kind of like playing COVID roulette.” This underscores the need for caution during summer travel and activities, even though the overall risk remains relatively mild. and I can’t stand up for …

Illness California Variants Report Covid Person Immune

5 months, 3 weeks ago

Endemic dengue may have helped stem severity of early COVID wave in India: study

The Hindu

Can the dengue virus beat the coronavirus and is it why the early wave of the pandemic in 2020 resulted in fewer COVID deaths or severe infections compared to Europe or North America where dengue is not endemic? “In this paper, we provided several pieces of experimentally obtained evidence that pre-existing dengue immunity might have played some protective role in …

India Dengue Covid Antibodies Coronavirus Strains

5 months, 3 weeks ago

As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign

Associated Press

NEW YORK — With fresh COVID-19 cases bubbling up in some parts of the country, health officials are setting course for a fall vaccination campaign. What’s more, health officials have reported upticks this month in COVID-19-associated emergency room visits and hospitalizations, and a pronounced increase in positive test results in the southwestern U.S. It’s not clear whether that’s a sign …

Health Month Officials Cdc Americans Health Officials Last Month

5 months, 3 weeks ago

As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

Month Officials Cdc Americans Health Officials Last Month

6 months, 1 week ago

Past COVID infections may help protect against certain colds. Could it lead to better vaccines?

Associated Press

If you’ve been sick with COVID-19, you may have some protection against certain versions of the common cold. A new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder coronavirus cousins, which could provide a key to broader COVID-19 vaccines. “We think there’s going to be a future outbreak of a coronavirus,” said Dr. Manish …

Covid Sagar Better Vaccines

6 months, 2 weeks ago

Positive test not needed for long COVID diagnosis, experts conclude

LA Times

People do not need to have tested positive for the coronavirus to be considered for a diagnosis of long COVID, a new report from the National Academies of Sciences, Engineering and Medicine concludes. The report, produced by a committee of experts at the request of the U.S. Social Security Administration, aims to summarize what is known about long COVID, a …

Test Long Covid Covid Long Report Conclude

6 months, 4 weeks ago

Why COVID vaccine safety needs scrutiny | Explained

The Hindu

The story so far: The Indian Council for Medical Research issued a letter to the researchers of Banaras Hindu University last week, countering their study on the side effects of India’s indigenous vaccine for COVID — Covaxin. The one-year observational, follow-up study titled ‘Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: Findings from a one-year prospective …

Safety Research Paper Study Letter Vaccine Researchers

7 months, 1 week ago

1 in 3 Covaxin takers reported adverse events, BHU study claims

Hindustan Times

A one-year follow-up study conducted by researchers at Banaras Hindu University has found that nearly one-third of individuals who received Bharat Biotech's Covaxin reported 'adverse events of special interest'. Read: AstraZeneca Covid vaccine related to another rare but deadly blood clotting disorder Adverse Events of Special Interest: Around 33% of participants reported AESI, with new-onset skin and subcutaneous disorders, general …

Covid Reported Study Participants Disorders Aesis Special Interest

7 months, 1 week ago

AstraZeneca's Covid vaccine linked to another rare blood disorder

India Today

Over a week after AstraZeneca announced a global withdrawal of its vaccine against coronavirus citing a slowdown in sales and availability of enough options in the market, new research has linked it to a rare disorder. Researchers found that the AstraZeneca vaccine, sold in India under the brand name Covishield, is linked to a rare blood clotting disorder called Vaccine-Induced …

Research Blood Covid Vaccine Flinders University Vitt Natural Adenovirus Infections

7 months, 1 week ago

Despite its ‘nothingburger’ reputation, COVID-19 remains deadlier than the flu

LA Times

Since the earliest days of the pandemic, health officials have gauged the threat of COVID-19 by comparing it to the flu. Immunity from vaccines and past coronavirus infections has helped tame COVID-19 to the point that when researchers compared the mortality rates of hospitalized COVID-19 and seasonal influenza patients during the height of the 2022-23 flu season, they found that …

Health Disease Patients Covid Cdc Flu Influenza

7 months, 2 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

India Covid Vaccines Covishield Vaccine

7 months, 2 weeks ago

There’s a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?

LA Times

Passengers with and without face masks travel through at Los Angeles International Airport in January. Two new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter’s dominant strain ahead of a possible summer uptick in coronavirus infections. “It’s been quite a while since we’ve had a new dominant variant in the U.S.,” said Dr. David Bronstein, an infectious …

Summer Risk California Covid Older Cdc Vaccine

7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

Vaccine Oxford Variant Astrazeneca Ema Side Effects Tts

7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

India Vaccines Vaccine Astrazeneca Covishield Sii Stopped Manufacturing

7 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

Blood Clots Blood Cause Covid Vaccine Astrazeneca Tts

7 months, 2 weeks ago

Stopped manufacturing Covishield since December 2021, says Serum Institute

Hindustan Times

Pune-based Serum Institute of India stopped manufacturing its anti-Covid-19 vaccine Covishield in 2021, according to a statement issued by the company on Wednesday after British-Swedish pharmaceutical manufacturer AstraZeneca announced it was withdrawing its vaccine against Covid, Vaxzevria, due to “commercial reasons” as demand for it decreased globally. Consequently, since December 2021, we have stopped the manufacturing and supply of additional …

India Vaccines Syndrome Ema 2021 Serum Institute Of India Serum Institute

7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

European Vaccine Astrazeneca Rna

7 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

Australia Vaccines Company Covid Available Vaccine Astrazeneca

7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

Rare Covid Vaccine Effect Jab Astrazeneca Vaxzevria

7 months, 3 weeks ago

Only 7 Out 10 Lakh May Face Clotting Risk Due to Covishield: Former ICMR Scientist

News 18

Only seven to eight individuals out of 10 lakh, who receive the coronavirus vaccine Covishield, face the risk of experiencing a rare side effect known as thrombosis thrombocytopenia syndrome. India’s top epidemiologist, former ICMR scientist Dr Raman Gangakhedkar, said those who got this vaccine have “no risk at all”. Gangakhedkar, who is known for his simplistic approach to clearing complicated …

Indian Risk Vaccine Icmr 10 Lakh Covishield Tts

7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

Covid Vaccine Astrazeneca Tts Safety Amid Safety Amid Rare Rare Side Effect

7 months, 3 weeks ago

Covid-19 or Seasonal Flu? Surge in Patients With Throat Pain, Cough & Fever Puts Doctors on Alert

News 18

Many states in India are witnessing a rise in upper respiratory tract illnesses, with symptoms like cough, cold, sore throat, and fever. “There is a definite rise in both upper and lower respiratory tract infections to the extent of 8-10 patients per week with about one-fourth of them serious enough to require hospitalisation.” The top symptoms, Das said, are throat …

India Delhi Cases Patients Hospital Symptoms Kochi

8 months, 1 week ago

COVID-19 in India | What is the current scenario and how are we tackling it?

The Hindu

Story so far: During this poll season, mentions of the COVID-19 pandemic are still doing the rounds. History of COVID-19 lockdown As COVID-19 cases – which were first reported in China’s Wuhan province – began cropping up across the world, countries employed different approaches to deal with the rise in infections, deaths and threat due to the virus, employing varying …

India Vaccination Uttar Pradesh States Cases West Bengal Crore

8 months, 3 weeks ago

GOP bill would require blood donor’s COVID vaccination status disclosure

Raw Story

A Louisiana Republican state lawmaker wants to require anyone in the state donating blood to disclose their COVID vaccination status, and wants to allow blood donation recipients to be given a choice of blood from donors who have or have not been vaccinated against the deadly virus. The bill reads: "Any person who collects human blood donations for the purpose …

Blood Republican State Status Louisiana Bill Wyoming